KORUS FTA sets new milestone for domestic drug makers

Published: 2007-06-14 06:58:00
Updated: 2007-06-14 06:58:00
Following the FTA ratification, Korea's pharmaceutical industry needs to enhance productivity and efficiency through restructuring.

But there are some bright spots. Korean companies now can bet on the possibility of mutual recognition arrangement (MRA) on generic drugs.

The conclusion of ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.